Abstract: Substituted heterocyclic compounds for treating multidrug resistance are disclosed. Compositions and methods of use for the substituted heterocyclic compounds are disclosed.
Type:
Grant
Filed:
December 19, 2000
Date of Patent:
February 17, 2004
Assignee:
The Procter & Gamble Company
Inventors:
Charles Raymond Degenhardt, David Joseph Eickhoff